Consolidated Statements of Cash Flows (USD $)	12 Months Ended
Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,473,913)us-gaap_ProfitLoss	$ (7,971,712)us-gaap_ProfitLoss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	907,540	860,254
Provision for doubtful accounts	(49,984)us-gaap_ProvisionForDoubtfulAccounts	133,726us-gaap_ProvisionForDoubtfulAccounts
Amortization of deferred financing costs	166,942us-gaap_AmortizationOfFinancingCosts	161,178us-gaap_AmortizationOfFinancingCosts
Change in fair value of warrant liability	0us-gaap_FairValueAdjustmentOfWarrants	5,392,594us-gaap_FairValueAdjustmentOfWarrants
Deferred income tax expense (benefit), net	288,178us-gaap_DeferredIncomeTaxExpenseBenefit	(590,414)us-gaap_DeferredIncomeTaxExpenseBenefit
Loss from equity investment in non-consolidated affiliate	0	502,518
Effect of changes in foreign exchange	4,564	284,962
Stock-based compensation expense	787,710us-gaap_ShareBasedCompensation	393,914us-gaap_ShareBasedCompensation
Provision for obsolete inventories	281,000	200,000
Changes in operations, assets and liabilities:
Accounts receivable	(1,671,925)	(1,959,593)
Due from affiliates	(23,462)	(193,680)
Inventory	(7,223,601)us-gaap_IncreaseDecreaseInInventories	(1,246,553)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and supplies	77,587	(591,188)
Other assets	(272,000)	(188,867)
Accounts payable and accrued expenses	1,321,722	(597,127)
Accrued interest	0	6,379
Due to related parties	27,642	(416,064)
Total adjustments	(5,378,087)	2,152,039
NET CASH USED IN OPERATING ACTIVITIES	(8,852,000)	(5,819,673)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(333,742)	(234,693)
Acquisition of intangible assets	(160,109)	(26,980)
Change in restricted cash	(929)	60,137
Payments under contingent consideration agreements	0	(5,940)
NET CASH USED IN INVESTING ACTIVITIES	(494,780)	(207,476)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from (payments on) Keltic facility	8,170,507	(4,548,284)
Payments on Bourbon term loan	(1,270,100)rox_PaymentForTermLoan	(481,000)rox_PaymentForTermLoan
(Payments on) proceeds from Junior loan	(1,250,000)rox_ProceedsFromOtherNotesPayable	1,250,000rox_ProceedsFromOtherNotesPayable
Proceeds from 5% Convertible notes	0us-gaap_ProceedsFromConvertibleDebt	2,125,000us-gaap_ProceedsFromConvertibleDebt
Net proceeds from (payments on) from foreign revolving credit facility	21,278	(73,797)
Proceeds from issuance of common stock	3,319,915	4,531,643
Payments for costs of stock issuance	(186,347)us-gaap_PaymentsOfStockIssuanceCosts	(184,341)us-gaap_PaymentsOfStockIssuanceCosts
Proceeds from exercise of common stock warrants	598,715us-gaap_ProceedsFromWarrantExercises	3,848,332us-gaap_ProceedsFromWarrantExercises
Proceeds from exercise of common stock options	222,984	25,976
NET CASH PROVIDED BY FINANCING ACTIVITIES	9,626,952	6,493,529
EFFECTS OF FOREIGN CURRENCY TRANSLATION	2,930	2,798
NET INCREASE IN CASH AND CASH EQUIVALENTS	283,102	469,178
CASH AND CASH EQUIVALENTS - BEGINNING	908,501	439,323
CASH AND CASH EQUIVALENTS - ENDING	1,191,603	908,501
Schedule of non-cash investing and financing activities:
Conversion of series A preferred stock to common stock	0us-gaap_ConversionOfStockAmountIssued1	8,349,539us-gaap_ConversionOfStockAmountIssued1
Conversion of 5% convertible note, and accrued interest thereon, to common stock	451,417	0
Surrender of common stock in connection with exercise of common stock warrant	31,250	0
Interest paid	937,973us-gaap_InterestPaid	867,782us-gaap_InterestPaid
Income taxes paid	$ 293,525us-gaap_IncomeTaxesPaidNet	$ 14,848us-gaap_IncomeTaxesPaidNet

The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods and supplies. Also includes, The increase (decrease) during the reporting period in other current operating assets not separately disclosed in the statement of cash flows.

No definition available.